Synergy CHC Corp Registers Resale Of Up To 101.7M Shares Under Equity Purchase Agreement With Potential $36M In Company Funding
Synergy CHC Corp. Reports First Quarter 2026 Financial Results
Synergy CHC Q1 EPS $(0.23) Misses $0.04 Estimate, Sales $5.493M Miss $9.528M Estimate
SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates
Synergy CHC shares are trading higher after Ascendiant Capital maintained a Buy rating and raised its price target from $5 to $5.5
Ascendiant Capital Maintains Buy on Synergy CHC, Raises Price Target to $5.5
Synergy CHC Shares Surge Nearly 100% In After-Hours Trading: What's Going On?
Synergy CHC Corp. Q4 2025 Earnings Call Summary
Synergy CHC Corp (SNYR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Seizing ...
Synergy CHC Corp (NASDAQ:SNYR) Plummets After Q4 Earnings and Revenue Miss Estimates
Synergy CHC Corp. Reports Fourth Quarter and Full Year 2025 Financial Results
Synergy CHC Corp. (SNYR) Q4 2025 Earnings Call Transcript
Synergy CHC Q4 EPS $(1.35), Sales $6.070M Miss $10.830M Estimate
Synergy CHC Corp. Announces Date Change of Fourth Quarter and Full Year 2025 Earnings and Conference Call
Synergy CHC Corp. Announces Fourth Quarter and Full Year 2025 Earnings and Conference Call Information
This Avalo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Ascendiant Capital Initiates Coverage On Synergy CHC with Buy Rating, Announces Price Target of $5
Synergy CHC Corp. (NASDAQ: SNYR) Expands FOCUSfactor® Functional Beverage Distribution Across Canada Through Walmart Canada and McKesson Canada
Synergy CHC Insider Ups Holding During Year
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.